About the Authors
- Madeleine White
-
Contributed equally to this work with: Madeleine White, Gill Webster
Affiliation School of Biological Sciences, Victoria University of Wellington, Wellington, New Zealand
- Gill Webster
-
Contributed equally to this work with: Madeleine White, Gill Webster
Affiliation Innate Immunotherapeutics, Auckland, New Zealand
- David O’Sullivan
-
Affiliation School of Biological Sciences, Victoria University of Wellington, Wellington, New Zealand
- Sarrabeth Stone
-
Affiliation School of Biological Sciences, Victoria University of Wellington, Wellington, New Zealand
- Anne Camille La Flamme
-
* E-mail: anne.laflamme@vuw.ac.nz
Affiliations School of Biological Sciences, Victoria University of Wellington, Wellington, New Zealand, Malaghan Institute of Medical Research, Wellington, New Zealand
Competing Interests
The authors can affirm that they have read the journal’s policy and have the following conflicts. GW is an employee of Innate Immunotherapeutics, which is commercializing MIS416 as an immune modulator for secondary progressive multiple sclerosis. However, this does not alter their adherence to all the PLOS ONE policies on sharing data and materials.
Author Contributions
Conceived and designed the experiments: MW GW DO ACL. Performed the experiments: MW GW DO SS ACL. Analyzed the data: MW GW DO SS ACL. Contributed reagents/materials/analysis tools: GW. Wrote the paper: MW GW ACL.